Brief: Spero Therapeutics Inc Files For Mixed Shelf Offering Of Up To $300 Million - SEC Filing
15/03/2024 20:42
March 15 (Reuters) - Spero Therapeutics Inc SPRO.O :
* SPERO THERAPEUTICS INC FILES FOR MIXED SHELF OFFERING OF
UP TO
$300 MILLION - SEC FILING
Source text for Eikon: ID:n0001193125-24-069196
Further company coverage: SPRO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spero Therapeutics
See all newsBrief: Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Spero Therapeutics - May Offer Up To $300 Million In Securities - SEC Filing
Brief: Spero Therapeutics Appoints Debra Jeske Zack, M.D., Ph.D., As Chief Medical Officer
Spero licenses Innovent's experimental immune disease drug for up to $1.1 billion
US FDA approves GSK's oral antibiotic for drug-resistant UTIs (updated)